This is a preview of subscription content, log in via an institution to check access.
Notes
2016 US dollars
Reference
Kabadi SM, et al. Adverse Events and Economic Burden Among Patients Receiving Systemic Treatment for Mantle Cell Lymphoma: A Real-World Retrospective Cohort Study. Anticancer Research 41: 927-936, No. 2, Feb 2021. Available from: URL: http://doi.org/10.21873/anticanres.14846
Rights and permissions
About this article
Cite this article
Systemic therapy for mantle-cell lymphoma: frequent costly AEs. PharmacoEcon Outcomes News 872, 28 (2021). https://doi.org/10.1007/s40274-021-7501-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7501-x